SAREPTA THERAPEUTICS, INC. Government Contract Receivable, Unbilled Amounts
SAREPTA THERAPEUTICS, INC. (SRPT) had Government Contract Receivable, Unbilled Amounts of $4.00 million as of 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Notes › Receivables
us-gaap:GovernmentContractReceivableUnbilledAmounts · last filed 2016-02-25
- 2015-12-31: Government Contract Receivable, Unbilled Amounts $4.00M.
- 2014-12-31: Government Contract Receivable, Unbilled Amounts $2.40M.
- 2014-09-30: Government Contract Receivable, Unbilled Amounts $2.50M.
- 2014-06-30: Government Contract Receivable, Unbilled Amounts $3.90M.
| Period end | Government Contract Receivable, Unbilled Amounts | Government Contract Receivable, Unbilled Amounts as first filed |
|---|---|---|
| 2015-12-31 | $4.00M 10-K · filed 2016-02-25 | |
| 2014-12-31 | $2.40M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $2.50M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $3.90M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $5.50M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $2.40M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $4.20M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $3.10M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $4.70M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $3.20M 10-K · filed 2014-03-03 | $3.25M 10-K · filed 2013-03-15 |
| 2012-09-30 | $2.47M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $4.22M 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $2.09M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |